Osborn Williams & Donohoe LLC increased its holdings in AmerisourceBergen Corp. (NYSE:ABC) by 48.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,655 shares of the company’s stock after acquiring an additional 2,500 shares during the quarter. Osborn Williams & Donohoe LLC’s holdings in AmerisourceBergen were worth $568,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. Massmutual Trust Co. FSB ADV increased its holdings in AmerisourceBergen by 48.4% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 1,877 shares of the company’s stock worth $140,000 after buying an additional 612 shares in the last quarter. Truvestments Capital LLC bought a new stake in AmerisourceBergen in the 1st quarter worth about $96,000. Nalls Sherbakoff Group LLC bought a new stake in AmerisourceBergen in the 4th quarter worth about $74,000. Clarkston Capital Partners LLC increased its holdings in AmerisourceBergen by 0.8% in the 4th quarter. Clarkston Capital Partners LLC now owns 92,628 shares of the company’s stock worth $6,892,000 after buying an additional 745 shares in the last quarter. Finally, Edmp Inc. increased its holdings in AmerisourceBergen by 1.3% in the 1st quarter. Edmp Inc. now owns 12,857 shares of the company’s stock worth $1,022,000 after buying an additional 165 shares in the last quarter. 65.71% of the stock is owned by institutional investors.
Several research firms recently commented on ABC. ValuEngine upgraded AmerisourceBergen from a “strong sell” rating to a “sell” rating in a report on Friday, May 3rd. Bank of America downgraded AmerisourceBergen from a “buy” rating to an “underperform” rating and cut their price target for the company from $95.00 to $76.00 in a research note on Wednesday, April 10th. Wolfe Research began coverage on AmerisourceBergen in a research note on Tuesday, April 2nd. They set a “market perform” rating for the company. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Monday, March 25th. Finally, Guggenheim began coverage on AmerisourceBergen in a research note on Thursday, April 11th. They set a “buy” rating for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $86.38.
Shares of ABC stock traded up $0.24 during trading hours on Friday, reaching $80.68. 780,066 shares of the company traded hands, compared to its average volume of 1,482,771. The company has a quick ratio of 0.56, a current ratio of 0.95 and a debt-to-equity ratio of 1.43. AmerisourceBergen Corp. has a 12-month low of $69.36 and a 12-month high of $94.88. The stock has a market cap of $16.93 billion, a P/E ratio of 12.43, a PEG ratio of 1.57 and a beta of 1.07.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $2.11 EPS for the quarter, topping the Zacks’ consensus estimate of $1.96 by $0.15. AmerisourceBergen had a return on equity of 46.24% and a net margin of 0.53%. The company had revenue of $43.32 billion for the quarter, compared to analysts’ expectations of $43.44 billion. During the same period in the previous year, the firm earned $1.94 EPS. The firm’s revenue was up 5.6% compared to the same quarter last year. On average, equities research analysts expect that AmerisourceBergen Corp. will post 6.81 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Monday, May 20th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, May 17th. This represents a $1.60 dividend on an annualized basis and a yield of 1.98%. AmerisourceBergen’s dividend payout ratio is presently 24.65%.
In related news, insider Dale Danilewitz sold 543 shares of the business’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $81.16, for a total value of $44,069.88. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Steven H. Collis sold 21,344 shares of AmerisourceBergen stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $83.62, for a total value of $1,784,785.28. Following the completion of the sale, the chief executive officer now directly owns 155,923 shares in the company, valued at approximately $13,038,281.26. The disclosure for this sale can be found here. Over the last three months, insiders purchased 2,018 shares of company stock worth $156,471 and sold 46,129 shares worth $3,723,512. 27.80% of the stock is currently owned by insiders.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Story: Penny Stocks, Risk and Reward Factors
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.